Evaluation of filaggrin 2 expression in dogs with atopic dermatitis before and after oclacitinib maleate administration

Documenti analoghi

• Evaluation of oclacitinib maleate and prednisolone combined therapy for the control of atopic dermatitis in dogs: A controlled clinical trial
  di: Tássia Sell Ferreira, et al.
  Pubblicazione: (2025)
• Comparative efficacy and safety of ilunocitinib and oclacitinib for the control of pruritus and associated skin lesions in dogs with atopic dermatitis
  di: Sophie Forster, et al.
  Pubblicazione: (2025)
• Comparative study of a commercial formula containing natural antimicrobials versus oral cephalexin or topical chlorhexidine‐miconazole therapies for treating superficial pyoderma in dogs
  di: Vanessa Cunningham Gmyterco, et al.
  Pubblicazione: (2025)
• Short‐term administration of oclacitinib with concomitant medications in canine epitheliotropic lymphoma: A retrospective study of eight dogs
  di: Yuta Baba, et al.
  Pubblicazione: (2025)
• Long‐term use of lokivetmab in dogs with atopic dermatitis
  di: Bettina Kasper, et al.
  Pubblicazione: (2024)